Sp43

MOLECULAR MARKERS FOR COLORECTAL CANCER RISK AND SCREENING: EMERGING APPROACHES

Date
May 18, 2024

Presenter

Speaker Image for William Grady
Fred Hutchinson Cancer Research Center

Tracks

Related Products

Thumbnail for OVERVIEW OF TECHNOLOGIES FOR MULTI-CANCER DETECTION (MCD) TESTS
Thumbnail for DEBATE: NON-ENDOSCOPIC TESTING FOR COLORECTAL CANCER: PRO - WILLIAM GRADY; CON - JENNIFER MARATT
Thumbnail for PANEL DISCUSSION
Thumbnail for MULTI-CANCER EARLY DETECTION TESTS
MULTI-CANCER EARLY DETECTION TESTS
Talks on the blood based screening test clinical trial results that will occur in 2022 and 2023 (ECLIPSE, PREEMPT, BLUE-C) and effects on clinical care; updates on multi-cancer early detection test; emerging screening tests (Oncoguard, Colonosight, etc)…